Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in MAFLD
NCT05984745Phase 2Recruiting
- Sponsor
- Ain Shams University
- Start
- Oct 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Coenzyme Q10 mucoadhesive tablets in metabolic dysfunction associated fatty liver disease (MAFLD), sponsored by Ain Shams University. Started Oct 2023; status: recruiting.
02
Drugs
Coenzyme Q10 mucoadhesive tablets
03
Conditions
metabolic dysfunction associated fatty liver disease (MAFLD)
Beyond the preview
Go deeper on NCT05984745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05984745.